Dopamine receptors and the dopamine hypothesis of schizophrenia (Q39471744)

12 September 2017

1 reference

title

Dopamine receptors and the dopamine hypothesis of schizophrenia (English)

1 reference

12 September 2017

0 references

0 references

Seeman P

1

1 reference

12 September 2017

1 January 1987

1 reference

12 September 2017

1 reference

12 September 2017

1

1 reference

12 September 2017

2

1 reference

12 September 2017

133-152

1 reference

Paradoxical reaction to L-dopa in schizophrenic patients

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Ventricular enlargement in schizophrenia: definition and prevalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

21 January 2018

Methylation Hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Psychotic reactions during tetraethylthiuramdisulfide (antabuse) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Fluorescent antibody studies of immunoglobulin binding by brain tissues. Demonstration of cytoplasmic fluorescence by direct and indirect testing in schizophrenic and nonschizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Central dopamine turnover in schizophrenic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Psychoses precipitated by psychotomimetic drugs. A follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Research in Endorphins and Schizophrenia*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The third biannual winter workshop on schizophrenia. Schladming, Austria, Jan 26-31, 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Plasma Proteins in Schizophrenia: A Review*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Are dopamine receptors present on human lymphocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. IV. The relationship between major depressive disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Estimating the genetic contribution to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Possible changes in striatal and limbic cholinergic systems in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Relevance of Dopamine Autoreceptors for Psychiatry: Preclinical and Clinical Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The pathogenesis of schizophrenia. Possible relationships between genetic, biochemical, and experiential factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

An anatomy of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The viral hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Neuropathological Studies of Schizophrenia: A Selective Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

The Effects of Ceruletide in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSYN.890010203

21 January 2018

Identifiers

DOI

10.1002/SYN.890010203

1 reference

12 September 2017

1 reference

PubMed ID

2905529